Your session is about to expire
← Back to Search
Body Positioning for Premature Birth
Study Summary
This trial is studying how body position affects a baby's breathing, oxygen, carbon dioxide, lung volume, and more.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Infants who cannot use NAVA due to certain medical conditions or cannot have a tube placed in their nose or mouth will not be included.My baby was born at or before 32 weeks and is on a non-invasive breathing support.My infant has persistent pulmonary hypertension.My infant has a heart condition present at birth.The baby must be using NAVA for at least 24 hours before joining the study and be doing well.
- Group 1: Prone positioning
- Group 2: Supine positioning
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Does the criteria for enrolment in this clinical trial include those aged 65 or older?
"Prospective participants of this trial must be of age between 1 Minute and 3 Months."
Is there a possibility for me to join this experiment?
"To partake in this investigation, participants must have ventilator lung and fit within the age bracket of 1 Minute to 3 Months. A total of 30 individuals are needed for inclusion into the trial."
Are there any vacancies for participants in this experiment?
"As seen on the clinicaltrials.gov website, this medical study is no longer actively recruiting participants - it was first posted in September of 2023 and last updated in July of that same year. Nevertheless, 303 other trials are still accepting patients at this time."
Share this study with friends
Copy Link
Messenger